Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2025 is 4.33% vs 8.74% in Jun 2025
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 4.84% vs 59.82% in Jun 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2025 is 8.52% vs 16.28% in Jun 2025
Interest
QoQ Growth in quarter ended Sep 2025 is -10.81% vs 23.33% in Jun 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
Compare Quarterly Results Of Vertex Pharmaceuticals, Inc. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is 4.33% vs 8.74% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 12.27% vs 11.86% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 4.84% vs 59.82% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 3.59% vs 0.98% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is 8.52% vs 16.28% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 12.11% vs 5.10% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is -10.81% vs 23.33% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -56.00% vs -31.19% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024






